We also observed increased tumoral innate cytokine levels and anti- tumor activity in response to treatment with the un-engineered EcN, supporting that our bacterial chassis itself is able to stimulate innate immunity in the TME, and this feature is further potentiated by arming it with STING agonist. This evidence concerns the gene STING1 and neoplasm.